Didn't find the company you were looking for? Our full system contains all Danish companies, including comprehensive credit risk reports. Register here to get started.

You can find text and video tutorials here that explain how to use our system.

REPONEX PHARMACEUTICALS A/S

CVR number: 30082346
Slotsmarken 18, 2970 Hørsholm
www.reponex.dk

Credit rating

Company information

Official name
REPONEX PHARMACEUTICALS A/S
Personnel
5 persons
Established
2006
Company form
Limited company
Industry
  • Expand more icon21Manufacture of basic pharmaceutical products and pharmaceutical preparations

About the company

REPONEX PHARMACEUTICALS A/S (CVR number: 30082346K) is a company from HØRSHOLM. The company recorded a gross profit of 0 kDKK in 2023. The operating profit was -16.6 mDKK, while net earnings were -14.3 mDKK. The profitability of the company measured by Return on Assets (ROA) was -76.6 %, which can be considered poor and Return on Equity (ROE) was -80.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 77.4 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. REPONEX PHARMACEUTICALS A/S's liquidity measured by quick ratio was 1.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
20192020202120222023
Volume
Net sales
Gross profit
EBIT-2 337.66-2 302.03-12 603.84-11 277.00-16 600.00
Net earnings-1 853.92-1 504.90-9 883.16-9 444.00-14 346.00
Shareholders equity total14 933.3413 428.4427 371.2318 911.0016 757.00
Balance sheet total (assets)17 501.7320 408.8728 708.1821 516.0021 662.00
Net debt-2 537.91- 135.75-11 403.25-2 830.00-1 938.00
Profitability
EBIT-%
ROA-17.2 %-12.1 %-51.3 %-44.9 %-76.6 %
ROE-21.4 %-10.6 %-48.4 %-40.8 %-80.4 %
ROI-30.3 %-17.9 %-63.9 %-48.0 %-90.1 %
Economic value added (EVA)-1 384.99- 595.79-8 685.75-9 727.58-14 263.67
Solvency
Equity ratio85.3 %71.0 %95.3 %87.9 %77.4 %
Gearing
Relative net indebtedness %
Liquidity
Quick ratio3.10.411.83.11.6
Current ratio3.80.612.83.11.6
Cash and cash equivalents2 537.91135.7511 403.252 830.001 938.00
Capital use efficiency
Trade debtors turnover (days)
Net working capital %
Credit risk
Credit ratingBBBBBBBBBBB

Variable visualization

ROA:-76.6%
Rating: 0/100
-20%
0%
4%
11%
24%
60%
Equity ratio:77.4%
Rating: 58/100
-1%
21%
50%
81%
99%
100%

Roles

Chairman of the board
Board member

Companies in the same industry

Build time: 2024-07-12T11:31:01.887Z

Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.